Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Professor Brendan Jenkins will lead the Tumour Inflammation and Immunotherapy program, which aims to identify ways to make tumours more visible to the body’s immune system and improve immune therapies.